Ambroxol — a chest congestion and cough medicine that’s being investigated for the treatment of Gaucher disease — has several molecular…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Thalassemia — a condition caused by a lack of hemoglobin in red blood cells — might be present in patients with…
A recent survey of people who were tested to see if they carry Gaucher disease-causing mutations in the GBA gene…
Lyso-Gb1 (glucosylsphingosine) may be a sensitive marker of disease burden and treatment response in patients with Gaucher disease type 1,…
Doctors who are not Gaucher disease experts should have straightforward and easy-to-follow diagnosis guidance so patients can be treated earlier,…
Poor bone health in people with Gaucher disease is likely driven by processes independent of the condition, researchers at Argentina’s …
The benefits of newborn screening for lysosomal storage disorders such as Gaucher disease were not directly apparent 15 months after…
Recommendations on Genetic Counseling for Gaucher-Parkinson’s Link Are Needed, Researchers Argue
Although people with Gaucher disease have a higher risk of developing Parkinson’s disease later in life, the link between the…
Regulatory agencies in the U.S. and Europe have joined forces to develop a proposal with the aim to spur innovative…
The presence of severe complications of Gaucher disease type 1 (GD1) at the time…